A Low‐Frequency Variant in MAPK14 Provides Mechanistic Evidence of a Link With Myeloperoxidase: A Prognostic Cardiovascular Risk Marker-Reference-Cited by-同舟云学术

A Low‐Frequency Variant in MAPK14 Provides Mechanistic Evidence of a Link With Myeloperoxidase: A Prognostic Cardiovascular Risk Marker

Published:2014-08-15 Issue:4 Volume:3 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Waterworth Dawn M.¹,Li Li²,Scott Robert³,Warren Liling²,Gillson Christopher³,Aponte Jennifer²,Sarov‐Blat Lea¹,Sprecher Dennis¹,Dupuis Josée⁴⁵,Reiner Alex⁶,Psaty Bruce M.⁷,Tracy Russell P.⁸,Lin Honghuang⁹⁸,McPherson Ruth¹⁰,Chissoe Stephanie²,Wareham Nick³,Ehm Margaret G.²

Affiliation:

1. GlaxoSmithKline, Philadelphia, PA

2. GlaxoSmithKline, Research Triangle Park, NC

3. MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK

4. Department of Biostatistics, Boston University School of Public Health, Boston, MA

5. Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology and Health Services, University of Washington, Seattle, WA

6. Group Health Research Institute, Group Health Cooperative, Seattle, WA

7. University of Vermont, Burlington, VT

8. Department of Medicine, Boston University School of Medicine, Boston, MA

9. Boston University and National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA

10. Division of Cardiology and Lipoprotein and Atherosclerosis Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Inhibition of p38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

2. The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale

3. An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People

4. Finding the missing heritability of complex diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic elucidation of the multi-target pharmacological mechanism of Terminalia arjuna against congestive cardiac failure via network pharmacology and molecular modelling approaches;Natural Product Research;2023-09-04

2. Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease;The Journal of Clinical Endocrinology & Metabolism;2021-08-07

3. Sex-specific epigenetic mediators between early life social disadvantage and adulthood BMI;Epigenomics;2018-06

4. Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns;Pharmacological Research;2018-05

5. Using Coexpression Protein Interaction Network Analysis to Identify Mechanisms of Danshensu Affecting Patients with Coronary Heart Disease;International Journal of Molecular Sciences;2017-06-19